跳至主要内容
临床试验/TCTR20181016001
TCTR20181016001已完成3 期

Analgesic efficacy of Nefopam in cancer pain: A randomized controlled study

Ramathibodi hospital0 个研究点目标入组 40 人开始时间: 2018年10月16日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • 1. Patients aged 18-80 years
  • 2. Patients who has moderate to severe cancer pain (numeric rating scale 4/10-10/10) who needs analgesics to control pain
  • 3. Patients who is willing to enroll the study

排除标准

  • 1. Patients who cannot evaluate their pain into numeric rating scale
  • 2. Patients who are not able to use IV-PCA machine
  • 3. Patients who are allergic to intravenous morphine
  • 4. Patients who are on chemotherapy or radiation therapy during study period
  • 5. Patients who undergo an operation within one week
  • 6. Patients with a history of convulsive disorder
  • 7. Patients who are diagnosed ischemic heart disease
  • 8. Patients who are taking MAOI within 30 days before study period
  • 9. Pregnants or breast feeing patients
  • 10. Patients who deny to enroll the study

研究者

相似试验